Neuland Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹776.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 76.54 per cent from ₹439.71 crore. This corresponds to a year-on-year *(YoY) growth of 136.40 per cent.
Operating Profit
Operating Profit stands at ₹307.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.46 per cent from ₹77.13 crore. This corresponds to a year-on-year *(YoY) growth of 501.78 per cent.
PBDT
PBDT stands at ₹312.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 298.75 per cent from ₹78.39 crore. This corresponds to a year-on-year *(YoY) growth of 456.29 per cent.
Profit Before Tax
Profit Before Tax stands at ₹287.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 427.80 per cent from ₹54.47 crore. This corresponds to a year-on-year *(YoY) growth of 631.53 per cent.
Net Profit
Net Profit stands at ₹212.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 424.21 per cent from ₹40.57 crore. This represents a 664.72 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Neuland Laboratories Ltd Earnings
- YOY
- QOQ
Neuland Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Neuland Laboratories Ltd Research Reports
Neuland Laboratories Ltd Financial Reports
Neuland Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Neuland Labs. | -1.74% | 0.49% | 16.03% | 27.97% | -3.35% | 51.65% |
| Sai Life | -0.85% | -0.62% | 7.89% | 13.54% | 27.77% | 55.07% |
| Piramal Pharma | -2.49% | -0.97% | 6.03% | 13.89% | -7.02% | -14.12% |
| Astrazeneca Phar | -3.66% | 0.90% | 2.33% | -1.62% | -4.34% | 9.73% |
| Pfizer | -0.49% | -0.73% | -3.97% | -6.04% | -6.96% | -15.99% |
| Natco Pharma | -1.26% | 0.20% | 7.39% | 22.86% | 33.78% | 36.24% |
| OneSource Speci. | -1.57% | -4.05% | 1.36% | 36.26% | 16.09% | 1.60% |
Company Info
Company Information
Executive Chairman : D R Rao
Non Executive Director : Christopher M Cimarusti
Vice Chairman & Chief Executive Officer : D Sucheth Rao
Vice Chairman & Managing Director : D Saharsh Rao
Company Sec. & Compli. Officer : Sarada Bhamidipati
Independent Director : Homi Rustam Khusrokhan
Independent Director : Prasad R Menon
Independent Director : Sugata Sircar
Independent Director : Pallavi Joshi Bakhru
Additional Director : Ravi Gopinath